T-2 toxemia and brain prostaglandins

Area of Science:

• Neuroscience
• Toxicology
• Biochemistry

Background:

• T-2 toxin, a trichothecene mycotoxin, is linked to elevated plasma eicosanoids.
• The cyclooxygenase pathway of arachidonate metabolism is crucial in various physiological processes.

Purpose of the Study:

• To investigate the impact of T-2 toxin on prostaglandin (PG) release from brain tissue.
• To elucidate the role of the arachidonate cascade in T-2 toxicosis pathophysiology.

Main Methods:

• In vivo administration of T-2 toxin to rats followed by brain slice analysis.
• In vitro incubation of rat brain slices with varying concentrations of T-2 toxin.
• Measurement of prostaglandin E2 (PGE2), thromboxane B2 (TXB2), and 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) release.

Main Results:

• In vivo T-2 toxin administration increased 6-keto-PGF1 alpha and TXB2 release in the cortex, and PGE2 in cortex and hypothalamus.
• In vitro studies showed T-2 toxin stimulated PGE2 and TXB2 release at low concentrations (10(-7) M) and inhibited PG release at high concentrations (>10(-4) M).
• Hypothalamic slices exhibited decreased PG release with very low or very high T-2 toxin concentrations.

Conclusions:

• T-2 toxin modulates eicosanoid release in specific brain regions.
• The arachidonate cascade in the central nervous system may play a role in T-2 mycotoxicosis.
• Further research is warranted to understand the neurotoxic mechanisms of T-2 toxin.